NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Solid Biosciences Inc (NASDAQ: SLDB)

 
SLDB Technical Analysis
5
As on 17th Apr 2025 SLDB STOCK Price closed @ 2.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.83 & Strong Sell for SHORT-TERM with Stoploss of 4.39 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SLDBSTOCK Price

Open 2.53 Change Price %
High 2.61 1 Day 0.03 1.19
Low 2.45 1 Week -0.12 -4.49
Close 2.55 1 Month -2.95 -53.64
Volume 1542012 1 Year 0.32 14.35
52 Week High 14.75 | 52 Week Low 2.07
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 101.49 -2.87%
PLUG 0.90 -2.17%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
INTC 18.93 -1.56%
TSLA 241.37 -0.07%
LILM 0.05 0.00%
PONO 1.72 2.38%
TELL 1.00 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
KZIA 3.30 364.79%
NDRAW 0.03 200.00%
MSGM 2.75 145.54%
WINVR 0.12 140.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ZVZZT 12.21 -81.24%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
LXEH 6.84 -70.25%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
TFFP 0.06 -62.50%
ATMH 0.05 -54.55%
 
 
SLDB
Daily Charts
SLDB
Intraday Charts
Whats New @
Bazaartrend
SLDB
Free Analysis
 
SLDB Important Levels Intraday
RESISTANCE2.86
RESISTANCE2.76
RESISTANCE2.70
RESISTANCE2.64
SUPPORT2.46
SUPPORT2.40
SUPPORT2.34
SUPPORT2.24
 
SLDB Forecast April 2025
4th UP Forecast14.9
3rd UP Forecast10.94
2nd UP Forecast8.49
1st UP Forecast6.04
1st DOWN Forecast-0.94
2nd DOWN Forecast-3.39
3rd DOWN Forecast-5.84
4th DOWN Forecast-9.8
 
SLDB Weekly Forecast
4th UP Forecast4.59
3rd UP Forecast3.94
2nd UP Forecast3.53
1st UP Forecast3.13
1st DOWN Forecast1.97
2nd DOWN Forecast1.57
3rd DOWN Forecast1.16
4th DOWN Forecast0.51
 
SLDB Forecast2025
4th UP Forecast27.7
3rd UP Forecast19.63
2nd UP Forecast14.65
1st UP Forecast9.66
1st DOWN Forecast-4.56
2nd DOWN Forecast-9.55
3rd DOWN Forecast-14.53
4th DOWN Forecast-22.6
 
 
SLDB Other Details
Segment EQ
Market Capital 229395696.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
SLDB Address
SLDB
 
SLDB Latest News
 
Your Comments and Response on Solid Biosciences Inc
 
SLDB Business Profile
Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles. Its portfolio also comprises Anti-LTBP4, a complementary disease modifying program that identifies and develops a monoclonal antibody intended to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein. In addition, the company engages in developing biomarkers and sensors; and Solid Suit program that includes the development of wearable assistive devices that focus on providing functional and therapeutic benefits. Solid Biosciences Inc. has strategic collaboration with Ultragenyx to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts. Address: 141 Portland Street, Cambridge, MA, United States, 02139
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service